Warning: The NCBI web site requires JavaScript to function. more...
Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.
Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC.
Harm Reduct J. 2009 Feb 20;6:3.
Related citations
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.
J Urban Health. 2008 May;85(3):309-22. Epub 2008 Mar 14.
Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.
Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Jarlais DD.
J Urban Health. 2009 Nov;86(6):918-28. Epub 2009 Nov 18.
Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
Rudolph AE, Crawford ND, Ompad DC, Benjamin EO, Stern RJ, Fuller CM.
J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):140-7.
Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN.
J Urban Health. 2010 Jul;87(4):534-42.
HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
Talu A, Rajaleid K, Abel-Ollo K, Rüütel K, Rahu M, Rhodes T, Platt L, Bobrova N, Uusküla A.
Int J Drug Policy. 2010 Jan;21(1):56-63. Epub 2009 Apr 22.
Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R; Diffusion of Benefit through Syringe Exchange Study Team.
Addiction. 2004 Sep;99(9):1136-46.
Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA, Weinstein B, Burris S, Jones TS.
AIDS. 2000 Jun;14 Suppl 1:S47-51.
Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia".
Werb D, Wood E.
Harm Reduct J. 2009 Nov 27;6:33.
Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G.
J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92.
Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
Singer M, Baer HA, Scott G, Horowitz S, Weinstein B.
Public Health Rep. 1998 Jun;113 Suppl 1:81-9.
Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
Khoshnood K, Blankenship KM, Pollack HA, Roan CT, Altice FL.
AIDS Public Policy J. 2000 Fall-Winter;15(3-4):88-94.
The impact of legalizing syringe exchange programs on arrests among injection drug users in California.
Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH.
J Urban Health. 2007 May;84(3):423-35.
Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J, Desenclos JC.
Addiction. 2005 Nov;100(11):1690-700. Erratum in: Addiction. 2006 Apr;101(4):616.
Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
Costenbader EC, Zule WA, Coomes CC.
Int J Drug Policy. 2010 Sep;21(5):425-8. Epub 2010 Jan 22.
Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia.
Uusküla A, Des Jarlais DC, Kals M, Rüütel K, Abel-Ollo K, Talu A, Sobolev I.
BMC Public Health. 2011 Jun 30;11:517.
Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.
Des Jarlais DC, McKnight C, Friedmann P.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S73-6.
A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
Finlinson HA, Oliver-Vélez D, Deren S, Cant JG, Colón HM, Robles RR, Kang SY, Andía JF.
Subst Use Misuse. 2006;41(9):1313-36.
Injection drug users report good access to pharmacy sale of syringes.
Reich W, Compton WM, Horton JC, Cottler LB, Cunningham-Williams RM, Booth R, Singer M, Leukefeld C, Fink J, Stopka TJ, Corsi KF, Tindall MS.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S68-72.
Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.
Gleghorn AA, Wright-De Agüero L, Flynn C.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S30-6.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on